Skip to main content

Journal Club - June 16, 2022


Miles Marchand presented the SODIUM-HF Trial which was an international, open-label, randomised, controlled trial comparing usual care according to local guidelines or a low sodium diet of less than 100 mmol (ie, <1500 mg/day) among patients with chronic heart failure (NYHA 2–3) and receiving optimally tolerated guideline-directed medical treatment. The primary outcome was the composite of cardiovascular-related admission to hospital, cardiovascular-related emergency department visit, or all-cause death within 12 months. The trial was presented at ACC in April and published in the Lancet.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC